(Q43934260)

28 November 2017

title

The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy (English)

1 reference

medroxyprogesterone acetate

28 November 2017

main subject

1 reference

based on heuristic

inferred from title

author

Inger Sundström-Poromaa

object named as

Sundström-Poromaa I

1 reference

28 November 2017

Bixo M

1 reference

28 November 2017

Torbjörn C. Bäckström

object named as

Bäckström T

1 reference

28 November 2017

Björn I

1 reference

28 November 2017

Nöjd KS

1 reference

28 November 2017

Collberg P

1 reference

28 November 2017

Nyberg S

1 reference

28 November 2017

publication date

1 February 2002

1 reference

Gynecological Endocrinology

28 November 2017

published in

1 reference

28 November 2017

1 reference

28 November 2017

1 reference

28 November 2017

page(s)

1-8

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

28 November 2017

1 reference

Progestogen intolerance and compliance with hormone replacement therapy in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

A meta-analysis of the effect of hormone replacement therapy upon depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Progestogen addition during oestrogen replacement therapy--effects on vasomotor symptoms and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Progesterone anesthesia in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Evidence that 5 alpha-pregnan-3 alpha-ol-20-one is the metabolite responsible for progesterone anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Chronic ethanol administration alters the modulatory effect of 5alpha-pregnan-3alpha-ol-20-one on the binding characteristics of various radioligands of GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Biphasic modulation of GABA(A) receptor binding by steroids suggests functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Characterisation of GABA(A) receptors in fetal, neonatal and adult ovine brain: region and age related changes and the effects of allopregnanolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Anxiogenic and non-anxiogenic benzodiazepine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Premenstrual Syndrome: A Double-Blind Controlled Trial of Progesterone and Placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FGYE.16.1.1.8

21 January 2018

Identifiers

DOI

10.1080/GYE.16.1.1.8

1 reference

28 November 2017

1 reference